Company reportsPresentationsAnnouncementsCurrently selectedAnnual General MeetingFinancial calendarCorporate governanceData of sharesConferences, roadshowsAnalystsContact Announcements Pharmacovigilance Risk Assessment Committee (PRAC) published new recommendations subsequent to the latest Esmya® referral09/04/20Composition of share capital and voting rights08/31/20Extraordinary announcement08/19/20Gedeon Richter Plc. hereby inform its shareholders, that according to the notice received from Hungarian National Asset Management Incorporated (hereinafter "HNMA Inc.") and Maecenas Universitatis Corvini Foundation (hereinafter "MUC Foundation") on 18 August, 2020 the transaction of transferring the 18,637,486 Richter common shares – owned by the Hungarian State and held in trust by Maecenas Universitatis Corvini Foundation – to the property of Maecenas Universitatis Corvini Foundation is closed. Extraordinary Announcement08/14/20Richter and its partner Palette Life Sciences AB received National Marketing Authorization in the United Kingdom for LIDBREE™08/04/20Gedeon Richter Plc. ('Richter') and Palette Life Sciences AB ('Palette'), today announced that as a part of a decentralised regulatory procedure including thirty European Economic Area member states, Richter and Palette received national marketing authorization for LIDBREE™ in the United Kingdom (UK). The product is a novel, proprietary thermo gelling intrauterine formulation that can provide significant pain relief during common gynaecological procedures. Archive
Pharmacovigilance Risk Assessment Committee (PRAC) published new recommendations subsequent to the latest Esmya® referral09/04/20
Extraordinary announcement08/19/20Gedeon Richter Plc. hereby inform its shareholders, that according to the notice received from Hungarian National Asset Management Incorporated (hereinafter "HNMA Inc.") and Maecenas Universitatis Corvini Foundation (hereinafter "MUC Foundation") on 18 August, 2020 the transaction of transferring the 18,637,486 Richter common shares – owned by the Hungarian State and held in trust by Maecenas Universitatis Corvini Foundation – to the property of Maecenas Universitatis Corvini Foundation is closed.
Richter and its partner Palette Life Sciences AB received National Marketing Authorization in the United Kingdom for LIDBREE™08/04/20Gedeon Richter Plc. ('Richter') and Palette Life Sciences AB ('Palette'), today announced that as a part of a decentralised regulatory procedure including thirty European Economic Area member states, Richter and Palette received national marketing authorization for LIDBREE™ in the United Kingdom (UK). The product is a novel, proprietary thermo gelling intrauterine formulation that can provide significant pain relief during common gynaecological procedures.
